IDEAS home Printed from https://ideas.repec.org/a/plo/pgph00/0001985.html
   My bibliography  Save this article

Factors associated with never treatment and acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana, 2021

Author

Listed:
  • Claudia Duguay
  • Reza A Niles-Robin
  • Charles R Thickstun
  • Horace Cox
  • Annastacia Sampson
  • Jean Seme-Fils Alexandre
  • Nathely Caleb-Mars
  • Charles W Goss
  • Ana Morice
  • Ronaldo G Carvalho Scholte
  • Alison Krentel

Abstract

Guyana remains one of four countries in the Americas endemic for lymphatic filariasis (LF). Elimination of LF requires repeated annual mass drug administration (MDA) with sufficient levels of coverage for success. This study assesses the acceptability and never treatment of LF MDA using data from a routine assessment survey in 2021. A subset of individuals, over 20 years of age (n = 2498), were selected to receive an expanded questionnaire to examine factors associated with acceptability and never treatment. Assessed factors include respondent demographics, knowledge, risk perceptions of LF, and opinions on the MDA programme. The majority (73%) of those with scores above the acceptability threshold (score ≥22.5) reported participating in MDA two or more times. Factors strongly and positively associated with scoring above the acceptability threshold include beliefs in importance of participation in MDA for their community (aOR = 2.8, 95%CI (1.1–7.2)), perception of importance of LF treatment (6.9 (3.2–14.7)), receiving treatment in 2021 (2.9 (1.5–5.4)), and the number of self-reported times taking treatment for LF (2.2 (1.1–4.4)). Ten percent of respondents participated in the MDA for the first time in 2021, while 15% reported never treatment during any round of LF MDA. Three factors were statistically associated with participation in MDA across the two levels of the models (level 1: took LF treatment once versus never, and level 2: took LF treatment twice versus never) included: 1) scoring above the acceptability threshold (aOR = 6.2, 95%CI(3.8–10.0)), 2) self-reported importance of participation in MDA for their community (7.1 (2.9–17.8)), and 3) personal beliefs that they should take LF treatment even if they are not sick (2.6 (1.7–3.9)). As Guyana moves closer to LF elimination, these results provide further insight and understanding into programmatic results and could inform further action following MDA activities—particularly if an approach is needed to address never treatment during MDA.

Suggested Citation

  • Claudia Duguay & Reza A Niles-Robin & Charles R Thickstun & Horace Cox & Annastacia Sampson & Jean Seme-Fils Alexandre & Nathely Caleb-Mars & Charles W Goss & Ana Morice & Ronaldo G Carvalho Scholte &, 2024. "Factors associated with never treatment and acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana, 2021," PLOS Global Public Health, Public Library of Science, vol. 4(4), pages 1-16, April.
  • Handle: RePEc:plo:pgph00:0001985
    DOI: 10.1371/journal.pgph.0001985
    as

    Download full text from publisher

    File URL: https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0001985
    Download Restriction: no

    File URL: https://journals.plos.org/globalpublichealth/article/file?id=10.1371/journal.pgph.0001985&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pgph.0001985?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. repec:plo:pntd00:0005027 is not listed on IDEAS
    2. Lynne Michelle Zeldenryk & Marion Gray & Richard Speare & Susan Gordon & Wayne Melrose, 2011. "The Emerging Story of Disability Associated with Lymphatic Filariasis: A Critical Review," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 5(12), pages 1-8, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. repec:plo:pntd00:0001768 is not listed on IDEAS
    2. Larry Sawers & Eileen Stillwaggon & John Chiphwanya & Square Z Mkwanda & Hannah Betts & Sarah Martindale & Louise A Kelly-Hope, 2020. "Economic benefits and costs of surgery for filarial hydrocele in Malawi," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 14(3), pages 1-15, March.
    3. Keetie Roelen & Caroline Ackley & Paul Boyce & Nicolas Farina & Santiago Ripoll, 2020. "COVID-19 in LMICs: The Need to Place Stigma Front and Centre to Its Response," The European Journal of Development Research, Palgrave Macmillan;European Association of Development Research and Training Institutes (EADI), vol. 32(5), pages 1592-1612, December.
    4. Brent, Robert J., 2016. "The value of reducing HIV stigma," Social Science & Medicine, Elsevier, vol. 151(C), pages 233-240.
    5. repec:plo:pntd00:0004954 is not listed on IDEAS

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pgph00:0001985. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: globalpubhealth (email available below). General contact details of provider: https://journals.plos.org/globalpublichealth .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.